Tech Company Financing Transactions

OpGen Funding Round

Private investors participated in a $1.1 million capital raise for OpGen. This venture round was announced on 7/17/2014.

Transaction Overview

Company Name
Announced On
7/17/2014
Transaction Type
Debt
Amount
$1,079,917
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd.
Gaithersburg, MD 20878
USA
Email Address
Overview
OpGen (NASDAQ: OPGN) is a leading provider of genetic analysis services and systems. The company's proprietary Optical Mapping system (see technology) is used by academic and commercial organizations worldwide for applications including comparative genomics and genome sequence assembly/validation.
Profile
OpGen LinkedIn Company Profile
Social Media
OpGen Company Twitter Account
Company News
OpGen News
Facebook
OpGen on Facebook
YouTube
OpGen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Oliver Schacht
  Oliver Schacht LinkedIn Profile  Oliver Schacht Twitter Account  Oliver Schacht News  Oliver Schacht on Facebook
Chief Financial Officer
Timothy Dec
  Timothy Dec LinkedIn Profile  Timothy Dec Twitter Account  Timothy Dec News  Timothy Dec on Facebook
Chief Marketing Officer
Faranak Atrzadeh
  Faranak Atrzadeh LinkedIn Profile  Faranak Atrzadeh Twitter Account  Faranak Atrzadeh News  Faranak Atrzadeh on Facebook
Chief Operating Officer
Johannes Bacher
  Johannes Bacher LinkedIn Profile  Johannes Bacher Twitter Account  Johannes Bacher News  Johannes Bacher on Facebook
VP - Bus. Development
Chris Emery
  Chris Emery LinkedIn Profile  Chris Emery Twitter Account  Chris Emery News  Chris Emery on Facebook
VP - Regulatory Affairs
Autumn Collasius
  Autumn Collasius LinkedIn Profile  Autumn Collasius Twitter Account  Autumn Collasius News  Autumn Collasius on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/17/2014: eXacly venture capital transaction
Next: 7/17/2014: Sensoria venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary